Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/40613
metadata.artigo.dc.title: Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
metadata.artigo.dc.creator: Giannis, Dimitrios
Ziogas, Ioannis A
Gianni, Panagiota
metadata.artigo.dc.subject: Coronavirus
COVID-19
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Middle East Respiratory Syndrome coronavirus (MERS-CoV)
Coagulation
Thrombosis
metadata.artigo.dc.publisher: Elsevier
metadata.artigo.dc.date.issued: Jun-2020
metadata.artigo.dc.identifier.citation: GIANNIS, D.; ZIOGAS, I. A.; GIANNI, P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of Clinical Virology, [S.l.], v. 127, June 2020.
metadata.artigo.dc.description.abstract: Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in China and rapidly spread worldwide. This novel strain is highly transmittable and severe disease has been reported in up to 16% of hospitalized cases. More than 600,000 cases have been confirmed and the number of deaths is constantly increasing. COVID-19 hospitalized patients, especially those suffering from severe respiratory or systemic manifestations, fall under the spectrum of the acutely ill medical population, which is at increased venous thromboembolism risk. Thrombotic complications seem to emerge as an important issue in patients infected with COVID-19. Preliminary reports on COVID-19 patients’ clinical and laboratory findings include thrombocytopenia, elevated D-dimer, prolonged prothrombin time, and disseminated intravascular coagulation. As the pandemic is spreading and the whole picture is yet unknown, we highlight the importance of coagulation disorders in COVID-19 infected patients and review relevant data of previous coronavirus epidemics caused by the severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and the Middle East Respiratory Syndrome coronavirus (MERS-CoV).
metadata.artigo.dc.identifier.uri: https://www.sciencedirect.com/science/article/pii/S1386653220301049
http://repositorio.ufla.br/jspui/handle/1/40613
metadata.artigo.dc.language: en_US
Appears in Collections:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.